MannKind Biopharmaceuticals Says in New Partnership Talks on Afrezza

Published: Feb 02, 2010

Bookmark and Share

Reuters -- MannKind Corp said it has opened partnership talks with "a few new parties" on its inhaled insulin product Afrezza and reengaged in talks with a previous candidate. In a conference call with analysts, the company also said it currently has enough cash to fund operations till at least the first quarter of 2011.

Back to news